MarketsandMarkets

Precision Medicine Conference

09th - 10th March 2023

ILEC Conference Centre & Ibis London Earls Court, London

Harnessing the Potential of Precision Medicine from Bench to Bedside

The healthcare sector is accelerating on a trajectory from ubiquitous treatment to truly personalized treatment. The advent of precision medicine has paved ways for customization and preventive health strategy development by utilizing the genetic information of the individual along with ethnicity, environment exposures, medical history and more. Surging trends in tailoring care have been a driving force for extensive research in this field from data research to target drug discovery.

MarketsandMarkets is delighted to announce its Precision Medicine Conference scheduled to be held on 9th-10th March 2023 in London, UK. The conference is intended to have interactive sessions on precision medicine, application of pharmacogenomics, complex diseases prediction and treatment, technological advancements in diagnosis of diseases, artificial intelligence and bigdata, challenges and ethical considerations in precision medicine.

The event encompasses networking sessions, panel discussions, solutions, and services catering to precision medicine. The conference will bring the full spectrum of experts, leaders, and stakeholders to share a board prospective on opportunities and overcoming the challenges faced during implementation of precision medicine in clinical practice.

CO-LOCATED CONFERENCES

7th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference
MarketsandMarkets Next-Gen Genomics and Proteomics Conference

WHAT TO EXPECT

  1. Overview of Precision Medicine and Genomic Science
  2. Precision Medicine in complex disease prediction and treatment – Chronic diseases, CAR T- cell immunotherapy in solid tumors
  3. Comprehensive Genomic profiling - Single cell sequencing using Liquid biopsy, Genetic screening by nextgeneration sequencing and whole genome sequencing
  4. Use of digital biomarkers for drug development, Multi-Omics prospects (Epigenomics, Proteomics, Transcriptomics, Pharmaco genomics)
  5. Inception of technologies for Precision Medicine – Impact of big data, Artificial intelligence, and Machine Learning, Insilico trials for Precision medicine
  6. Cost benefit issues, Regulatory, Ethical and Social challenges in Precision Medicine
  7. Future purview of Precision Medicine, New beginning – Digital health

  • Witness live action how precision medicine is revolutionizing the future of healthcare
  • Quality insights and cohesiveness of key issues and obstacles experienced by the healthcare providers while implementing precision medicine
  • Discover the different avenues in patient centric care
  • Comprehend the current and future regulatory prospects for approval of diagnostic tests
  • Discuss the emerging technologies and opportunities with cutting edge strategies
  • Opportunity for one-on-one networking with the delegates and extend professional competency
  • Panel discussion with great lineup of experts

  • Industry: Pharma/Therapeutic Companies/Start Up’s
  • CEOs, CMO’s, CSO’s, COO’s, Presidents, Vice Presidents, Directors, Managing Directors, Head of Departments, Executive Leaders, Pharmacists, Oncologists, Immunologists, Geneticists, Principal Scientists, Big Data Scientists, Business Development, Regulatory and Policy Advisors, Diagnostic Laboratory Professionals, Global Leaders.
  • Departments: Oncology, Personalized medicine, Immunology, Molecular Biology, Genetics and genomic medicine, Molecular Medicine, Pharmacogenomics, Biotechnology
  • Academics: Universities, Research Institutes, Hospitals
  • Head of Departments, Professors, Lecturers, Senior Scientists, Researchers, Bioinformaticians
  • Departments: Oncology, Personalized medicine, Immunology, Molecular Biology, Genetics and genomic medicine, Molecular Medicine, Pharmacogenomics, Biotechnology

CONFERENCE AGENDA

Registration

08:15 - 08:50

Welcome Note by MarketsandMarkets!

08:50 - 08:55

Opening Remarks by the Chairperson

Milena Kalaitsidou

Milena Kalaitsidou, Principal Scientist, Instil Bio

08:55 - 09:00

Precision Medicine in Disease Prediction & Treatment

Keynote Rho kinase (ROCK) as a Therapeutic Target in Cancer

Victoria Sanz Moreno

Victoria Sanz Moreno, Professor of Cancer Cell Biology, Queen Mary University of London

09:00 - 09:30

Achieving precision medicine in chronic diseases: from patient-focused drug discovery to personalized prediction, prevention, and treatment

Sandy Hogg

Sandy Hogg, SVP Alliance Management, PrecisionLife

09:30 - 10:00

Enabling precision medicine: Autoantibody Analysis in Liquid Biopsies

Cyndie Forestier

Cyndie Forestier, Field Application Scientist, Sengenics

10:00 - 10:30

Morning Refreshments | One-to-One Networking Meeting

10:30 - 11:20

Precision Medicine Approaches to Tumor Oncology

CAR T-cell immunotherapy of solid tumours: Parallel learning from the clinic and lab

John Maher

John Maher, Chief Scientific Officer, Leucid Bio

11:20 - 11:50

Use of tumour-associated antigen targeting Humabodies to deliver CD137 agonism to the tumour microenvironment

Andrew Pierce

Andrew Pierce, Vice President, Translational Biology, Crescendo Biologics

11:50 - 12:20

From Cytometry to Tissue Imaging: CyTOF Technology made Straightforward

Carole Chedid

Carole Chedid, Field Application Specialist, Standard BioTools

12:20 - 12:50

RNA Activation in Genetic and Acquired Diseases

Nagy Habib

Nagy Habib, Founder and Head of R&D, MiNA Therapeutics

12:50 - 13:20

Lunch | One-to-One Networking

13:20 - 14:20

Use of Spatial Transcriptomics to Identify Differentially Expressed Biological Pathways in SEGA Brain Tumours from Patients with Tuberous Sclerosis Complex

Hywel Williams

Hywel Williams, Senior Lecturer in Bioinformatics, School of Medicine, Division of Cancer and Genetics, Cardiff University

14:20 - 14:50

RNA Biomarkers for Human Cancers

Arijit  Mukhopadhyay

Arijit Mukhopadhyay, Reader in Human Genetics, University of Salford

14:50 - 15:20

Enhancement of anti-tumour reactivity using a costimulatory antigen receptor (CoStAR) platform: T cell activity tuning

Milena Kalaitsidou

Milena Kalaitsidou, Principal Scientist, Instil Bio

15:20 - 15:50

Evening Refreshments | One-to-One Networking

15:50 - 16:30

Phage-guided delivery of nucleic acid therapeutics in oncology and other human diseases

Amin Hajitou

Amin Hajitou, Professor, Chair of Targeted Therapies, Imperial College of London

16:30 - 17:00

Closing Remarks by the Chairperson

Milena Kalaitsidou

Milena Kalaitsidou, Principal Scientist, Instil Bio

17:00 - 17:00

Drinks Reception and Networking

17:00 - 17:00

End of Day 1

17:00 - 17:00

Registration

08:15 - 08:50

Welcome Note by MarketsandMarkets

08:50 - 08:55

Opening Remarks by the Chairperson

Samaneh Kouchaki

Samaneh Kouchaki, Lecturer, Machine Learning, University of Surrey

08:55 - 09:00

Comprehensive Genomic Profiling

Engineering Gamma Delta T Cells to Supercharge Cytotoxic Function, Persistence, and Safety

Caroline Hull

Caroline Hull, Associate Director, Leucid Bio

09:00 - 09:30

Droplet Microfluidics for personalized cancer therapy Droplet Microfluidics for Personalized Cancer Therapy

Christoph A. Merten

Christoph A. Merten, , École Polytechnique Fédérale de Lausanne (EPFL)

09:30 - 10:00

Large Scale Implementation of Population Wide Polygenic Risk Scores

Manuel Corpas

Manuel Corpas, Scientific Director, Cambridge Precision Medicine

10:00 - 10:30

Morning Refreshments | One-to-One Networking

10:30 - 11:15

Using digital biomarkers for a precision medicine approach to neuroscience drug development

Jennifer Barnett

Jennifer Barnett , CEO, Monument Therapeutics

11:15 - 11:45

Unsupervised Data-driven Anomaly Detection and Biomarker Discovery Approach for Detection of Adverse Health Conditions in People Living with Dementia

Samaneh Kouchaki

Samaneh Kouchaki, Lecturer, Machine Learning, University of Surrey

11:45 - 12:15

Multi-OMICS led Precision Cardiology- The Model of Heart Failure

Dhavendra Kumar

Dhavendra Kumar, Honorary Clinical Professor, The William Harvey Research Institute, Bart’s School of Medicine & Dentistry, Queen Mary University of London

12:15 - 12:45

Development of Deep-Learning Resources for Computational Histopathology and Outcome Prediction in Oesophageal and Skin Cancer

Jun Wang

Jun Wang, Senior Lecturer – Bioinformatics, Barts Cancer Institute/ Queen Mary University of London

12:45 - 13:15

Lunch | One-to-One Networking

13:15 - 14:15

Integrating Health Data into Biobanks for Precision Medicine

Ali Abbasi

Ali Abbasi, Visiting Senior Researcher-Precision Medicine, University Medical Center Groningen (UMCG)

14:15 - 14:45

Closing remarks by the Chairperson

14:45 - 14:45

End of Conference

14:45 - 14:45

CONFERENCE SPEAKERS

ADVISORS

Manuel Corpas

Manuel Corpas

Scientific Director, Cambridge Precision Medicine

Alex F Frangi

Alex F Frangi

Diamond Jubilee Chair in Computational Medicine & RAEng Chair in Emerging Technologies, University of Leeds & KU Leuven - Turing Fellow

SPEAKERS

Sandy Hogg

Sandy Hogg

SVP Alliance Management, PrecisionLife

Dhavendra Kumar

Dhavendra Kumar

Honorary Clinical Professor, The William Harvey Research Institute, Bart’s School of Medicine & Dentistry, Queen Mary University of London

Caroline Hull

Caroline Hull

Associate Director, Leucid Bio

Amin Hajitou

Amin Hajitou

Professor, Chair of Targeted Therapies, Imperial College of London

Milena Kalaitsidou

Milena Kalaitsidou

Principal Scientist, Instil Bio

Arijit Mukhopadhyay

Arijit Mukhopadhyay

Reader in Human Genetics, University of Salford

John Maher

John Maher

Chief Scientific Officer, Leucid Bio

Christoph A. Merten

Christoph A. Merten

, École Polytechnique Fédérale de Lausanne (EPFL)

Andrew Pierce

Andrew Pierce

Vice President, Translational Biology, Crescendo Biologics

Jennifer Barnett

Jennifer Barnett

CEO, Monument Therapeutics

Manuel Corpas

Manuel Corpas

Scientific Director, Cambridge Precision Medicine

Nagy Habib

Nagy Habib

Founder and Head of R&D, MiNA Therapeutics

Victoria Sanz Moreno

Victoria Sanz Moreno

Professor of Cancer Cell Biology, Queen Mary University of London

Hywel Williams

Hywel Williams

Senior Lecturer in Bioinformatics, School of Medicine, Division of Cancer and Genetics, Cardiff University

Samaneh Kouchaki

Samaneh Kouchaki

Lecturer, Machine Learning, University of Surrey

Cyndie Forestier

Cyndie Forestier

Field Application Scientist, Sengenics

Carole Chedid

Carole Chedid

Field Application Specialist, Standard BioTools

Jun Wang

Jun Wang

Senior Lecturer – Bioinformatics, Barts Cancer Institute/ Queen Mary University of London

Ali Abbasi

Ali Abbasi

Visiting Senior Researcher-Precision Medicine, University Medical Center Groningen (UMCG)

ENQUIRE NOW

SPONSORS

PARTNERS

LOCATION

Venue

ILEC Conference Centre & Ibis London Earls Court, London

PAST EVENT GALLERY